Monoclonal Antibody-Based Regimens for Early Relapse Multiple Myeloma

Early Relapse in Multiple Myeloma: Modern Management Strategies

Monoclonal Antibody-Based Regimens for Early Relapse Multiple Myeloma

ReachMD Healthcare Image
Media formats available:
  • Overview

    Recognizing and treating early relapse of multiple myeloma (MM) is a challenge for healthcare professionals. This program is designed to improve clinicians’ ability to distinguish between relapse and progression of disease in MM. In addition, the program compares the efficacy and safety of carfilzomib- and pomalidomide-based regimens in the treatment of relapsed MM, applies current and emerging treatment approaches to MM patients in early relapse, and reviews common adverse events that occur when using combination regimens to treat early relapsed myeloma.

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, including community and academic medical oncologists/hematologists, advanced practice professionals, oncology nurses, oncology pharmacists, as well as other clinicians involved in the management of patients with multiple myeloma (MM).

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Distinguish between relapse and progression of disease in multiple myeloma
    • Compare the efficacy and safety of carfilzomib- and pomalidomide-based regimens in the treatment of relapsed multiple myeloma
    • Apply current and emerging treatment approaches to multiple myeloma patients in early relapse
    • Recognize common adverse events seen with combination regimens used to treat early relapsed multiple myeloma
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Noa Biran, MD, faculty for this educational event, receives research support from Merck, Amgen, BMS, Karyopharm, and Janssen; receives consulting fees from  Sanofi, Amgen, Takeda, Karyopharm, GSK, Janssen, Pfizer, and BMS; and spouse is an employee for Boehringer Ingelheim.   

    Joseph Mikhael, MD, MEd, FRCPC, faculty for this educational event, receives research support from BMS; and receives consulting fees from Amgen, BMS, Janssen, Sanofi, and Takeda. 

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    Robert Garris, PharmD, MPH, planner for this educational event, has no relevant financial relationships with ineligible companies.

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    Total CME, LLC., planners, and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Acknowledgment

    This activity is supported by an independent educational grant from Bristol Myers Squibb.

    Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.

  • Instructions for Completion

    During the period 8/25/2023 through 8/25/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:

    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free